Kinetic evidence for multiple aggregation pathways in antibody light chain variable domains

Abstract

AbstractAggregation of antibody light chain proteins is associated with the progressive disease light chain amyloidosis. Patient‐derived amyloid fibrils are formed from light chain variable domain residues in non‐native conformations, highlighting a requirement that light chains unfold from their native structures in order to aggregate. However, mechanistic studies of amyloid formation have primarily focused on the self‐assembly of natively unstructured peptides, and the role of native state unfolding is less well understood. Using a well‐studied light chain variable domain protein known as WIL, which readily aggregates in vitro under conditions where the native state predominates, we asked how the protein concentration and addition of pre‐formed fibril “seeds” alter the kinetics of aggregation. Monitoring aggregation with thioflavin T fluorescence revealed a distinctly non‐linear dependence on concentration, with a maximum aggregation rate observed at 8 μM protein. This behavior is consistent with formation of alternate aggregate structures in the early phases of amyloid formation. Addition of N‐ or C‐terminal peptide tags, which did not greatly affect the folding or stability of the protein, altered the concentration dependence of aggregation. Aggregation rates increased in the presence of pre‐formed seeds, but this effect did not eliminate the delay before aggregation and became saturated when the proportion of seeds added was greater than 1 in 1600. The complexity of aggregation observed in vitro highlights how multiple species may contribute to amyloid pathology in patients.This article is protected by copyright. All rights reserved.